T1	Participants 473 562	Patients with newly diagnosed metastatic breast cancer or locally recurrent breast cancer
T2	Participants 667 675	patients
T3	Participants 785 789	arms
T4	Participants 1080 1089	Both arms
T5	Participants 1208 1219	49 patients
